Missing content? – Request curation!
Request curation for specific Genes, Variants, or PubMed publications.
Have questions, comments, or suggestions? - Let us know!
Email us at : ckbsupport@genomenon.com
ID | DOID:81312 |
Name | T-cell non-Hodgkin lymphoma |
Definition | A non-Hodgkin lymphoma of T-cell lineage. |
Source | DiseaseOntology.org |
Alt Ids | |
Path | disease disease of cellular proliferation cancer organ system cancer hematologic cancer lymphoma non-Hodgkin lymphoma T-cell non-Hodgkin lymphoma |
Molecular Profile | Therapy | Indication/Tumor Type | Response Type | Profile Response Detail |
---|
Clinical Trial | Phase | Therapies | Title | Recruitment Status | Covered Countries | Other Countries |
---|---|---|---|---|---|---|
NCT05313243 | Phase II | Brentuximab vedotin + Pembrolizumab | Pembrolizumab and Brentuximab Vedotin in Subjects With Relapsed/Refractory T-cell Lymphoma | Recruiting | USA | 0 |
NCT05996185 | Phase II | Cyclophosphamide + Doxorubicin + Etoposide + Mogamulizumab + Prednisone + Vincristine Sulfate | Study of Mogamulizumab With DA-EPOCH in Patients With Aggressive T Cell Lymphoma | Not yet recruiting | USA | 0 |
NCT06018129 | Phase Ib/II | GEN3017 | A First-in-human Trial of GEN3017 in Hodgkin Lymphoma and Non-Hodgkin Lymphoma | Recruiting | USA | AUS | 0 |
NCT06420089 | Phase I | Cyclophosphamide + Fludarabine + Senza5 CART5 Senza5 CART5 | CD5-deleted Chimeric Antigen Receptor Cells (Senza5 CART5) for T Cell Non-Hodgkin Lymphoma (NHL) (VIPER101) | Recruiting | USA | 0 |
NCT06492304 | Phase Ib/II | CTX131 | A Safety and Efficacy Study Evaluating CTX131 in Adult Subjects With Relapsed/Refractory Hematologic Malignancies | Recruiting | USA | 0 |